Dr. Esha Kaul 
Director
17 Years of ExperienceBone Marrow Transplant Surgeon, Hematologist, Medical Oncologist
MBBS, Fellowship
Max Multi Speciality Centre, Noida
Max Super Speciality Hospital, Vaishali, Ghaziabad
English, Hindi
Consultation Fee ₹ 1000
Book an AppointmentAbout Dr. Esha Kaul
- Dr. Esha Kaul is a well-known Medical Oncologist, Hematologist, and Bone Marrow Transplant Specialist with over 17 years of experience.
- She specializes in plasma cell disorders such as myelodysplastic syndromes, multiple myeloma, amyloidosis, and myeloproliferative disorders.
- Her educational qualifications include an MBBS from All India Institute of Medical Sciences (AIIMS), New Delhi, 2006, and an Internship from Albert Einstein Medical Center, Philadelphia, USA, 2009
- She further achieved a residency (Internal medicine) and a fellowship (Hematology-oncology) from Tufts University, Boston, USA, in 2011 and 2014.
- She received multiple accolades, including the Abstract Achievement Award and Institute Book Prize, during her undergraduate studies at AIIMS.
- Dr. Kaul is recognized for academic excellence, ranked among the top 30 students nationwide, and nominated for the Sorel Catherine Freyman Gold Medal in Pediatrics.
- She is a member of prestigious organizations, including the American Society of Bone Marrow Transplant, International Myeloma Society, American Society of Transplant and Cellular Therapy, and American Society of Hematology.
- Dr. Kaul is fluent in English and Hindi.
Book Your Appointment With Dr. Esha Kaul
Get a Treatment Plan Within 1 Hour
Education
- MBBS, All India Institute of Medical Sciences (AIIMS), New Delhi, 2006
- Internship, Albert Einstein Medical Center, Philadelphia, USA, 2009
- Residency (Internal Medicine), Tufts University, Boston, USA, 2011
- Fellowship (Hematology-Oncology), Tufts University, Boston USA, 2014
Past Experience
- Junior Resident (Employee Health Services), All India Institute of Medical Sciences, New Delhi, 2007
- Intern (Internal Medicine), Albert Einstein Medical Center, Philadelphia, PA, 2009
- Resident (Internal Medicine), Tufts Medical Center, Boston, MA, 2011
- Associate Consultant (Hematology- Oncology/Bone Marrow Transplant), BL Kapoor Super Speciality Hospital, New Delhi, 2016
- Executive Consultant (Hematology- Oncology/Bone Marrow Transplant), Jaypee Hospital, Noida
Awards
- Received Award of Excellence for being in the top 30 students in the country in the Indian National Biology Olympiad, 2001.
- Ranked No. 1 in the All India Armed Forces Medical College Entrance Examination, 2001.
- Received Certificate of Merit for being among the top 0.1% of successful candidates in English in All India Senior School Certificate Examination, 1999.
- Received the Priyaneet Aujla Memorial Award for the Best All-Round Student, St. Peter's Academy, 1999.
Associations/Membership
- American Society of Hematology
- Indian Society of Bone Marrow Transplant
- American Society of Transplant and Cellular Therapy
- International Myeloma Society
Paper Published
- Agarwal N, Pandey P, Kaul E, Dhingra N, Kumar P. Mechanical Cryopreservation of peripheral blood stem cell: Initial experience from a tertiary care hospital. Indian J Hematol Blood Transfus 2019 in print
- Chaulagain CP, Sprague KA, Pilichowska M, Cowan J, Klein AK, Kaul E, Miller KB. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 2019 Apr;54(4):560-566
- Kaul E; Precision medicine in Hematological Malignancies; Pharma Times, March 2019
- Kaul E; Platelet transfusions: When, What and How Much? Management of platelet disorders in clinical practice: UP Journal of Internal Medicine, March 2019
- Sehgal T, Singh P, Kaul E; Stodtmeister Cells (Polymorphs with Pelger-Huët Anomaly) Showing "Faggots" in Mixed Phenotypic Acute Leukemia (T/Myeloid). Indian J Hematol Blood Transfus. 2018 Jan;34(1):148-150
- Kaul E, Sharma SK; Multiple Myeloma; Looking beyond standards; Asian Journal of Oncology; Jan-Mar 2016; 2(1) 23-28,
- Sharma SK, Choudhary D, Kaul E, et al. Hematopoietic Stem Cell Transplant in Elderly Patients: Experience from a Tertiary Care Centre in Northern India; Indian J Hematol Blood Transfus 2016 Jun; 32(Suppl1) 205-207.
- Kaul E, Shah G, Chaulagain C, Comenzo R: Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis; BMT; 2014 Sep;49(9):1233
- Kaul E, Pilichowska M, Vullaganti M, Madan N, Comenzo R; Twists and Turns of Determining Amyloid Type and Amyloid-related Organ Damage: Discordance and Clinical Skepticism in the Era of Proteomic Typing. Amyloid, 2014 Mar; 21(1):62-5.
- Shah G, Kaul E, Klein A, Miller K, Cossor F, Fallo S, Sprague K, Comenzo R: Open Label Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: A Retrospective Chart Review of Response Rates and Toxicity; Clinical Therapeutics,2013 October;35(10) 1614-20.
- Kaul E, Dhingra N; Successful Allogenic and Autologous Transplant with Concurrent Usage of Direct-Acting Antivirals for Hepatitis C in Children with Hematological Malignancies, accepted for publication at SIOP 2019
- Khandelwal V, Choudhary D, Sharma S, Kharya G, Kaul E, Kothari S, Doval D, Setia R, Handoo A: Haploidentical Hematopoietic Stem Cell Transplant for Thalassaemia Major Using pre-transplant immunosuppression and Post Transplant Cyclophosphamide; Accepted for presentation at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation; Valencia, Spain; 2016
- Esha Kaul, Sweta Kothari, Rasika Setia, Sanjeev Sharma, Saad Suleiman, Vipin Khandelwal, Gaurav Kharya, Bharti Sharma, Anil Handoo and Dharma Choudhary: Peripheral Blood Stem Cell Collection on Day 4 Is Feasible and Safe in a Majority of Allogeneic Stem Cell Transplant Donors; ASBMT Feb 2016; Honolulu, Abstract #483
- Esha Kaul, Sweta Kothari, Rasika Setia, Sanjeev Sharma, et al.; Day 4 Peripheral Blood Stem Cell Collection in Myeloma Patients is Feasible and Cost-effective in a Majority of Patients; Abstract presented at the 15th International Myeloma Workshop; September 2015; Rome, Italy; PO#155
- Vyas O, Kaul E, Rosenberg A, Shah G, Shah U, Comenzo RL et al.; Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis. Poster presentation at American Society of Hematology meeting December 2014 # 3170
- Shah G, Kaul E, Comenzo R. High Response Rates and Minimal Toxicity with Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients Systemic AL Amyloidosis. International Symposium on Amyloidosis. 2014. Oral presentation
- Kaul E, Shah G, Comenzo R; Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis: Update of a Single Center Experience; Poster presentation at 2014 BMT Tandem Meetings # 144
- Chaulagain C, Sprague K, Klein A, Pilichowska M, Kaul E, Miller K; Squamous Cell Cancers of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation; Poster presentation at 2014 BMT Tandem Meetings
- Shah G, Rosenberg A, Kaul E, Stevenson R, Chin J, Shah U, Dinitz A, Cossor F, Smith H, Klein A, Comenzo R, Miller K, Van Etten R, Siegel R, and Sprague K. Improvement of Blood Glucose Control on the Bone Marrow Transplant (BMT) Unit: A Retrospective Review of Our Quality Improvement Pilot Program. (ASBMT Annual Meeting Abstracts). 2013; # 306.
- Kaul E, Flores JP, Paulus J, Gunturu K, Hematology and Oncology; Natural Allies or Time to Part Ways? Results of a Medicine Resident Survey. American Society of Hematology meeting December 2013, Poster # 2920
- Kaul E, Shah G, Comenzo R; Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis: a Single Center Experience. American Society of Hematology Meeting December 2013, Poster # 4516
- Chaulagain C, Kaul E, Miller K; Clinicopathologic Characteristics of Secondary Non-Hematologic Malignancies in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Blood, October 2013, Vol 122, 5496
Field of Expertise
- ABO Incompatible Transplant
- Adrenal Cancer Treatment
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Benign and Cancerous Tumor Excision
- Bile Duct Cancer Treatment
Best Oncology Doctors in India
Dr. Ashok Kumar Vaid
Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Satya Pal Kataria
Vice Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Chandragouda Dodagoudar
Director
Medical Oncologist
BLK-Max Super Speciality Hospital, New Delhi
Book an Appointment Talk To Expert
Dr. Kunjahari Medhi
Senior Director
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert